key: cord-0691584-2u7fvs0b authors: Bruni, Teresa; Lalvani, Ajit; Richeldi, Luca title: Reply to Fenton et al.: An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel Rooms date: 2020-10-15 journal: Am J Respir Crit Care Med DOI: 10.1164/rccm.202008-3063le sha: bd7278f5462e3a1b869d12c942aaa91fd044da72 doc_id: 691584 cord_uid: 2u7fvs0b nan Reply to Fenton et al. We really thank Fenton and colleagues for their interest in our article (1) and the pleasing comments regarding our telemedicine-supported hotel accommodation model for patients with coronavirus disease . Our project, which allowed 258 patients with COVID-19 to be discharged from the hospital to the hotel, was performed in the period from April 1 to May 31, 2020, during the Italian COVID-19 epidemic peak, when the number of infections was at its maximum, the need for hospital beds was urgent, and the future perspective of the outbreak was uncertain. The connection between the timing of such a model and the infection peak is a crucial aspect, to guarantee a rapid response to the epidemic and at the same time to contain unnecessary costs. Our timing was very appropriate for the Lazio region peak: the cost-effectiveness analysis of the project is ongoing. Moreover, a decisive feature of this model is its flexibility: the capacity to modify the offered service, such as personnel, number of active rooms, and provision of other side services, in a fluid way adaptable day by day to contagions and resources guaranteed by different nations with different realities in terms of epidemiology and health systems enables this model to potentially fit to all the countries seriously affected by the pandemic to better cope with the outbreak. Our model evolved over time: the number of nurses varied according to the number of hotel guests; physiotherapy and psychological counseling services were born following the needs that patients presented during their accommodation; the meal service was adapted to the health and cultural requirements of the patients, such as Easter or Ramadan time. Of course, this model should be adapted to the different sociocultural and epidemiological settings: if this type of management is to be efficient, the few "basic" requirements (e.g., isolation and feasibility of testing) will need to be mixed with other "additional" features (e.g., security and psychological support) to build the best solution, which will be different from country to country and within the same country during different phases of the epidemic. Medical staff present in the hotel included geriatricians, normally operating in the continuity care service, who managed the in and out flow of patients, the swab timing, and the relationship with the public hygiene office that regulated the isolation conclusion. Patients' arrival in the facility was subject to compliance with the inclusion criteria mentioned in the paper (1) to guarantee a good quality of accommodation and telemonitoring, despite the limited health resources that a hotel can guarantee compared with a hospital. Three pulmonologist doctors provided medical availability 24 hours a day and were in charge of remote control of vital signs; a phone, an oximeter, and a thermometer were given to each patient with all the instructions for correctly sending parameters to the central platform. A telephone helpdesk support was made available to minimize the time patients required to familiarize themselves with the telemonitoring tools. Our model ended up with 254 patients with negative severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) swabs who were discharged home: 4 patients who were still positive were transferred to other health facilities. Currently, the number of infections in Italy has greatly reduced, thus allowing the hotel to be converted back to its original function. The experience provided by such a useful project could enable a rapid reinstatement in case of need for possible COVID-19 second waves. For this reason, healthcare managers should define contractual arrangements with hotel facilities in advance to be ready to activate them quickly if needed. We are very thankful to Fenton and colleagues for the interest received, delighted to see how our model has been reproduced To the Editor: The recent article by Quaife and colleagues (1) and the accompanying editorial by Burnett-Hartman and Wiener (2) report the results of the LSUT (Lung Screen Uptake Trial) from London and provide comments from Boston. The trial is important because it provides evidence that there may be ways to improve the dismal uptake of lung cancer screening, especially in higher-risk, underserved populations. The editorialists point out some differences between the United Kingdom and United States, including the important fact that patient contact came from the individual primary care physician, which is in contrast to the approach used in the United States, where many patients do not have an identifiable primary care physician. There are other important factors, including the emphasis on the "Lung Health Check" rather than on more narrow lung cancer screening and the absence of copays or other financial disincentives for computed tomographic scans in the United Kingdom compared with the United States. In PLuSS (Pittsburgh Lung Screening Study) (3), we have also emphasized total lung health by providing annual spirometry, and we have eliminated financial barriers by waving all copays. We have also been using the electronic health record to identify potential candidates for lung screening. As our ability to obtain more information from the low-dose computed tomographic scans by radiomic advances, we hopefully can rebrand lung cancer screening in the United States, maybe as heart and lung screening, to facilitate more widespread use. n Telemedicine-enabled accelerated discharge of patients hospitalized with COVID-19 to isolation in repurposed hotel rooms Lung Screen Uptake Trial (LSUT): randomized controlled clinical trial testing targeted invitation materials Lessons learned to promote lung cancer screening and preempt worsening lung cancer disparities The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan We read Wilson's response letter to both our LSUT (Lung Screen Uptake Trial) (1) and the accompanying editorial by Burnett-Hartman and Wiener (2) with great interest and value the insightful discussion they raise. Together we share in the challenge of achieving both equitable and informed uptake of low-dose computed tomography lung cancer screening by high-risk individuals, but the differences between the United Kingdom and United States that Wilson raises are important for how we intervene. The United Kingdom benefits from a coordinated and universal primary care system, and we appreciate that sending postal invitations directly from the individual's primary care physician is a strategy that may not translate